|
Login
Directory:
Add Company
| Your company can benefit
from enhanced listings. Questions? Read our FAQ
first. |
Personalized notification service and newsletter info
| Subscribe (free) to get notified
of new additions. |
Learn more About us and about our Services
Contact us
|
Zoplicone 
|
|
Readily available Recent EU registration dossier
Offer available for: licensing Pharmaceutical form and dosage: 7,5 mg Tablets Type:
- Generics
- Pharmaceuticals / Therapeutics
- Prescription drugs (Rx)
Therapeutic target:
- Central nervous system
Action: Psycholeptics (CNS) |
|
|
Full Description: Zoplicone dossier: -New readily available for licensing -Marketing Authorization soon to be obtained in Belgium and The Netherlands (we can also register in other countries) -Stability: 25°C: 30 months + continued, 40°C: 6 months
Availability and Market information:
Status: Registration
Market(s) and Registration Info: (date: concerns Marketing Authorization) - Belgium : 2001 - Netherlands : 2001 Registration info: On request: registration in other countries BE available
Market information
Other Market Info:
Patent Information: Name: Imovane
Patent info: Expired
|
Suggestion box |
Disclaimer | Privacy
Policy | Rules & Regulations
Copyright© Cofidei, Inc. Last modified: 31-Oct-2001.
|